Overview
Castle Biosciences, Inc. is a molecular diagnostics company that develops and commercializes genetic tests to assess cancer risk and guide treatment decisions for patients with melanoma, skin cancer, and other malignancies including esophageal adenocarcinoma, cutaneous squamous cell carcinoma, mesothelioma, and dermatologic cancers. The company utilizes next-generation sequencing technology to provide clinically actionable diagnostic insights that help oncologists and dermatologists personalize patient care and improve outcomes.
More in Clinical Diagnostics
Latest industry news
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?
2026-10-10 · Product
Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns
2026-10-09 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →